Rossi AB, et al. - The added clinical benefit and tolerability of a medical device repairing emollient creams (MDREC) when used in association with a moderately potent topical corticosteroid (TCS) was examined for adults with atopic dermatitis (AD). Compared to the TCS cream alone, all secondary measures of lesion severity decreased more with the combined TCS + MDREC treatment. Using MDREC along with TCS during AD flares and as a maintenance therapy after stopping the treatment with TCS were supported herein.